Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study - Jones, D; Boudes, P F; Swain, M G (Lancet Gastroenterol Hepatol, 2017)